The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The present and future of nanotechnology in human health care
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Semiconductor Nanocrystals as Fluorescent Biological Labels
Bruchez, M., Moronne, M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,613
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
The use of nanocrystals in biological detection
Alivisatos, P. (2004) · Nature Biotechnology · doi:10.1038/nbt927 · Cited by 3,008
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Nanoparticles – known and unknown health risks
Hoet, P. H., Brüske-Hohlfeld, I., & Salata, O. V. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-12 · Cited by 1,374
Enhanced functions of osteoblasts on nanophase ceramics
Webster, T. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00075-2 · Cited by 1,324
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationPanyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Self-citationSpecific proteins mediate enhanced osteoblast adhesion on nanophase ceramics
Webster, T. J., Ergun, C., Doremus, R. H., Siegel, R. W., & Bizios, R. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3<475::aid-jbm23>3.0.co;2-9 · Cited by 989
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Single-quantum-dot-based DNA nanosensor
Zhang, C.-Y., Yeh, H.-C., Kuroki, M. T., & Wang, T.-H. (2005) · Nature Materials · doi:10.1038/nmat1508 · Cited by 953
Engineered Nanomaterials for Biophotonics Applications: Improving Sensing, Imaging, and Therapeutics
West, J. L., & Halas, N. J. (2003) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.5.011303.120723 · Cited by 890
The 'right' size in nanobiotechnology
Whitesides, G. M. (2003) · Nature Biotechnology · doi:10.1038/nbt872 · Cited by 843
Self-illuminating quantum dot conjugates for in vivo imaging
So, M.-K., Xu, C., Loening, A. M., Gambhir, S. S., & Rao, J. (2006) · Nature Biotechnology · doi:10.1038/nbt1188 · Cited by 807
Converging Technologies for Improving Human Performance
(2003) · Springer eBooks · doi:10.1007/978-94-017-0359-8 · Cited by 794
Nanotechnology: convergence with modern biology and medicine
Roco, M. C. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00068-5 · Cited by 763
Woo, K. M., Chen, V. J., & Ma, P. X. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10098 · Cited by 714
Template-imprinted nanostructured surfaces for protein recognition
Shi, H., Tsai, W.-B., Garrison, M. D., Ferrari, S., & Ratner, B. D. (1999) · Nature · doi:10.1038/19267 · Cited by 684
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Xu, Y., Piston, D. W., & Johnson, C. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.151 · Cited by 617
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
DEMANUELE, A., & ATTWOOD, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.012 · Cited by 571
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
Emerich, D. F., & Thanos, C. G. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.4.655 · Cited by 510
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Nanotechnologies for biomolecular detection and medical diagnostics
Cheng, M. M.-C., Cuda, G., Bunimovich, Y. L., Gaspari, M., Heath, J. R., Hill, H. D., Mirkin, C. A., Nijdam, A. J., Terracciano, R., Thundat, T., et al. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.01.006 · Cited by 474
Nanotechnology in clinical laboratory diagnostics
Jain, K. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.014 · Cited by 453
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Biomédical applications of nanotechnology — implications for drug targeting and gene therapy
Davis, S. S. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01036-6 · Cited by 416
Nanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
Absi, E. G., Addy, M., & Adams, D. (1987) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.1987.tb01533.x · Cited by 410
Engineered nanoparticles as precise drug delivery systems
Yih, T. C., & Al‐Fandi, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20796 · Cited by 392
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
El-Shabouri, M. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00461-1 · Cited by 392
Selective bone cell adhesion on formulations containing carbon nanofibers
Price, R. L., Waid, M. C., Haberstroh, K. M., & Webster, T. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00609-9 · Cited by 392
Nanodiagnostics: application of nanotechnology in molecular diagnostics
Jain, K. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.2.153 · Cited by 372
Gene Therapy Progress and Prospects: Electroporation and other physical methods
Wells, D. J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302337 · Cited by 372
The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Kayser, O., Lemke, A., & Hernandez-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 349
Multicolor quantum dots for molecular diagnostics of cancer
Smith, A. M., Dave, S., Nie, S., True, L., & Gao, X. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.2.231 · Cited by 348
Applications of nanotechnology to biotechnology
West, J. L., & Halas, N. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00082-3 · Cited by 342
Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants
Webster, T. J., Waid, M. C., McKenzie, J. L., Price, R. L., & Ejiofor, J. U. (2004) · Nanotechnology · doi:10.1088/0957-4484/15/1/009 · Cited by 334
Targeted Drug Delivery in Cancer Therapy
Vasir, J. K., & Labhasetwar, V. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400405 · Cited by 327
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
Chitosan–PEG nanocapsules as new carriers for oral peptide delivery
Prego, C., Torres, D., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.015 · Cited by 308
Commercializing nanotechnology
Mazzola, L. (2003) · Nature Biotechnology · doi:10.1038/nbt1003-1137 · Cited by 290
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Regulatable gene expression systems for gene therapy applications: progress and future challenges
Goverdhana, S., Puntel, M., Xiong, W., Zirger, J. M., Barcia, C., Curtin, J. F., Soffer, E. B., Mondkar, S., King, G. D., Hu, J., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.022 · Cited by 283
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
Hu, L., Tang, X., & Cui, F. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044959 · Cited by 281
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Vascular complications after balloon and new device angioplasty.
Popma, J. J., Satler, L. F., Pichard, A. D., Kent, K. M., Campbell, A., Chuang, Y. C., Clark, C., Merritt, A. J., Bucher, T. A., & Leon, M. B. (1993) · Circulation · doi:10.1161/01.cir.88.4.1569 · Cited by 268
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Drug delivery in biotechnology: present and future
Orive, G., Hernández, R. M., Gascón, A. R., Domı́nguez-Gil, A., & Pedraz, J. L. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.007 · Cited by 223
Xu, L., Pirollo, K. F., Tang, W.-H., Rait, A., & Chang, E. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016357 · Cited by 218
The role of nanobiotechnology in drug discovery
Jain, K. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03573-7 · Cited by 207
FREITAS, R. A. (2000) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2000.0084 · Cited by 192
Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century
Kricka, L. J. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00451-x · Cited by 186
Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications
Sato, M., & Webster, T. J. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.105 · Cited by 176
Lutsiak, M. E. C., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020452531828 · Cited by 163
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology
Wickline, S. A., Neubauer, A. M., Winter, P. M., Caruthers, S. D., & Lanza, G. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201069.47550.8b · Cited by 158
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression
Prabha, S., & Labhasetwar, V. D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016250.56402.99 · Cited by 150
Vector-mediated drug delivery to the brain
Pardridge, W. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00087-8 · Cited by 146
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Arangoa, M. A., Campanero, M. Á., Renedo, M. J., Ponchel, G., & Irache, J. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1013018111829 · Cited by 138
Labhasetwar, V. D. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.10.009 · Cited by 138
Luminescent Quantum Dots: A Very Attractive and Promising Tool in Biomedicine
Weng, J., & Ren, J.-C. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361076 · Cited by 132
de Kozak, Y., Andrieux, K., Villarroya, H., Klein, C., Thillaye‐Goldenberg, B., Naud, M., Garcia, E., & Couvreur, P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425022 · Cited by 130
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
Xu, L., Pirollo, K. F., & Chang, E. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00324-8 · Cited by 128
Prabha, S., & Labhasetwar, V. D. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049970+ · Cited by 128
Supramolecular structures from dendrons and dendrimers
Al‐Jamal, K. T., Ramaswamy, C., & Florence, A. J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.015 · Cited by 126
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Intravascular and Endobronchial DNA Delivery to Murine Lung Tissue Using a Novel, Nonviral Vector
Kukowska‐Latallo, J. F., Chen, C., Raczka, E., Qunintana, A., Rymaszewski, M., & Baker, J. R. (2000) · Human Gene Therapy · doi:10.1089/10430340050057468 · Cited by 116
Nanomedicine – prospective therapeutic and diagnostic applications
Emerich, D. F. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.1 · Cited by 113
García-García, E., Gil, S., Andrieux, K., Desmaële, D., Nicolas, V., Taran, F., Georgin, D., Andreux, J. P., Roux, F. S., & Couvreur, P. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5094-3 · Cited by 105
Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines
Cui, Z., & Mumper, R. J. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.10 · Cited by 105
Nanotechnology applications in medicine.
Wilkinson, J. M. (2003) · PubMed · Cited by 102
Nanocapsules as Drug Delivery Systems
Mayer, C. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502801114 · Cited by 99
Zhang, Y., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2003) · PubMed · Cited by 95
Optimisation of dendrimer‐mediated gene transfer by anionic oligomers
Maksimenko, A., Mandrouguine, V., Gottikh, M., Bertrand, J., Majoral, J., & Malvy, C. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.319 · Cited by 92
Molecular Imaging Applications in Nanomedicine
Li, K. C., Pandit, S. D., Guccione, S., & Bednarski, M. D. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000031747.05317.81 · Cited by 90
Cationic Liposomes for Gene Delivery: Novel Cationic Lipids and Enhancement by Proteins and Peptides
Düzgüneş, N., de Ilarduya, C. T., Simões, S., Zhdanov, R. I., Konopka, K., & de Lima, M. C. P. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457403 · Cited by 75
p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome
Nakase, M., Inui, M., Okumura, K., Kamei, T., Nakamura, S., & Tagawa, T. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0196 · Cited by 72
Arbós, P., Campanero, M. Á., Arangoa, M. A., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.006 · Cited by 67
Nanomedicine transforms drug delivery
Shaffer, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03654-8 · Cited by 58
Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver
Liu, L., Zern, M. Α., Lizarzaburu, M. E., Nantz, M. H., & Wu, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301861 · Cited by 54
Dourda, A. O., Moule, A. J., & Wg, Y. (1994) · International Endodontic Journal · doi:10.1111/j.1365-2591.1994.tb00252.x · Cited by 54
The Diameter of Dentinal Tubules in Human Coronal Dentine after Demineralization and Air Drying
Arends, J. J. A., Stokroos, I., Jongebloed, W., & Ruben, J. L. (2009) · Caries Research · doi:10.1159/000262052 · Cited by 39
ENTERING THE ERA OF MOLECULAR DENTISTRY
SLAVKIN, H. C. (1999) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1999.0212 · Cited by 38
Mauro Ferrari, B., & Downing, G. J. (2005) · BioDrugs · doi:10.2165/00063030-200519040-00001 · Cited by 38
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
Hamon, M., cluse, E. L., Monassier, J., Grollier, G., & Potier, J. C. (1998) · Drugs & Aging · doi:10.2165/00002512-199813040-00005 · Cited by 30
Freitas, R. A. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.08.003 · Cited by 30
Tiny Solutions for Giant Cardiac Problems
Kong, D. F., & Goldschmidt‐Clermont, P. J. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.07.003 · Cited by 23
Nanotechnology and Public Health: Contributions, Promises, and Premises
Matsuda, M., Goto, A., Ogino, T., & Tanaka, Y. (2013) · doi:10.1002/9781118451915.ch3 · Cited by 20
Clinical trials in interventional cardiology
Popma, J. J., Piana, R. N., & Prpic, R. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199909000-00009 · Cited by 7
Cited by
Synthesis of metallic nanoparticles using plant extracts
Mittal, A. K., Chisti, Y., & Banerjee, U. C. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.01.003 · Cited by 2,671
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Self-citationNanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Self-citationPremanathan, M., Karthikeyan, K., Jeyasubramanian, K., & Manivannan, G. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.001 · Cited by 1,098
Metadata
- Authors
- Sahoo, S. K., Parveen, S., & Panda, J. J.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 3
- Issue
- 1
- Pages
- 20-31
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2140071828
- Cited by
- 905
- References
- 105
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.